EFHC2 nalazi se na negativnom lancu (čulni lanac) X hromosoma na poziciji p11.3. To je jedan od nekoliko odabranih gena sa dokazima in vitro, koji sugeriraju da mogućnos izbjegavanja inaktivacije X-a.[6]EFHC2 obuhvata 195.796 baznih parova i susjed je gena NDP koji kodira protein Norriejeve bolesti. Preliminarni dokazi zasnovani na studijama povezanosti genoma našli su vezu sa SNP u intronu između egzona 13 i 14 iz EFHC2 sa izbjegavanjem oštećenja.[7]
Srodni protein, EFHC1 kodiran je genom na hromosomu 6. Pretpostavlja se da su oba proteina uključena u razvoj epilepsije[12][13] te da ovaj gen može biti povezan s prepoznavanjem straha kod osoba s Turnerovim sindromom.[5]Mutacija u EFHC2 koja rezultira supstitucijom serina u tirozin na aminokiselinskom položaju 430 (S430Y) povezana je sa juvenilnom mioklonskom epilepsijom u njemačkom muškom stanovništvu.[12] Pored toga, jednonukleotidni polimorfizam u EFHC2 korelira sa smanjenom sposobnošću pacijenata sa Turnerovim sindromom da prepoznaju strah u izrazu lica ;[14] međutim, ovi nalazi ostaju kontroverzni.[15]
^Castagné R, Zeller T, Rotival M, Szymczak S, Truong V, Schillert A, Trégouët DA, Münzel T, Ziegler A, Cambien F, Blankenberg S, Tiret L (Nov 2011). "Influence of sex and genetic variability on expression of X-linked genes in human monocytes". Genomics. 98 (5): 320–6. doi:10.1016/j.ygeno.2011.06.009. PMID21763416.
^Blaya C, Moorjani P, Salum GA, Gonçalves L, Weiss LA, Leistner-Segal S, Manfro GG, Smoller JW (Mar 2009). "Preliminary evidence of association between EFHC2, a gene implicated in fear recognition, and harm avoidance". Neuroscience Letters. 452 (1): 84–6. doi:10.1016/j.neulet.2009.01.036. PMID19429002.
^Wilkins MR, Gasteiger E, Bairoch A, Sanchez JC, Williams KL, Appel RD, Hochstrasser DF (1999). "Protein identification and analysis tools in the ExPASy server". Methods in Molecular Biology. 112: 531–52. doi:10.1385/1-59259-584-7:531. PMID10027275.
^Horton P, Nakai K (1997). "Better prediction of protein cellular localization sites with the k nearest neighbors classifier". Proceedings of the International Conference on Intelligent Systems for Molecular Biology. 5: 147–52. PMID9322029.
^ abGu W, Sander T, Heils A, Lenzen KP, Steinlein OK (2005). "A new EF-hand containing gene EFHC2 on Xp11.4: tentative evidence for association with juvenile myoclonic epilepsy". Epilepsy Research. 66 (1–3): 91–8. doi:10.1016/j.eplepsyres.2005.07.003. PMID16112844.
^Suzuki T, Delgado-Escueta AV, Aguan K, Alonso ME, Shi J, Hara Y, Nishida M, Numata T, Medina MT, Takeuchi T, Morita R, Bai D, Ganesh S, Sugimoto Y, Inazawa J, Bailey JN, Ochoa A, Jara-Prado A, Rasmussen A, Ramos-Peek J, Cordova S, Rubio-Donnadieu F, Inoue Y, Osawa M, Kaneko S, Oguni H, Mori Y, Yamakawa K (Aug 2004). "Mutations in EFHC1 cause juvenile myoclonic epilepsy". Nature Genetics. 36 (8): 842–9. doi:10.1038/ng1393. PMID15258581.
^Rodriguez-Revenga L, Madrigal I, Alkhalidi LS, Armengol L, González E, Badenas C, Estivill X, Milà M (maj 2007). "Contiguous deletion of the NDP, MAOA, MAOB, and EFHC2 genes in a patient with Norrie disease, severe psychomotor retardation and myoclonic epilepsy". American Journal of Medical Genetics Part A. 143A (9): 916–20. doi:10.1002/ajmg.a.31521. PMID17431911.
^Zinn AR, Kushner H, Ross JL (Jun 2008). "EFHC2 SNP rs7055196 is not associated with fear recognition in 45,X Turner syndrome". American Journal of Medical Genetics Part B. 147B (4): 507–9. doi:10.1002/ajmg.b.30625. PMID17948898.